{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:39:22Z","timestamp":1791585562037,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.euroneuro.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:29:44Z","timestamp":1719199784000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Do classic psychedelics increase the risk of seizures? A scoping review"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-4280","authenticated-orcid":false,"given":"\u00d3scar","family":"Soto-Angona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0754-4011","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mart\u00ednez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estevo","family":"Santamarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9 Gil","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gite Moos","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-2876","authenticated-orcid":false,"given":"Gen\u00eds","family":"Ona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.euroneuro.2024.05.002_bib0001","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.05.002_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.05.002_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.05.002_bib0005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10072-017-2887-8","article-title":"Psychogenic nonepileptic seizures: a concise review","volume":"38","author":"Asadi-Pooya","year":"2017","journal-title":"Neurolog. Sci.: Off. J. Ital. Neurolog. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0006","first-page":"1200","article-title":"The use of lysergic acid diethylamide (LSD) in psychotherapy","volume":"91","author":"Baker","year":"1964","journal-title":"Can. Med. Assoc. J."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0007","first-page":"e24310","article-title":"Syndrome of inappropriate antidiuretic hormone secretion following Ayahuasca use in a satanic ritual: a case report","volume":"14","author":"Bayat Mokhtari","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1214969","article-title":"Case report: psychedelic-induced seizures captured by intracranial electrocorticography","volume":"14","author":"Blond","year":"2023","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.euroneuro.2024.05.002_bib0009","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.2174\/1570159X20666220411081728","article-title":"What is the role of lithium in epilepsy?","volume":"20","author":"Bojja","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2024.05.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000438","article-title":"Adverse effects of ayahuasca: results from the Global Ayahuasca Survey","volume":"2","author":"Bouso","year":"2022","journal-title":"PLOS Global Public Health"},{"issue":"10","key":"10.1016\/j.euroneuro.2024.05.002_bib0011","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/02698811221116926","article-title":"Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review","volume":"36","author":"Breeksema","year":"2022","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.05.002_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1941874414528939","article-title":"Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine","volume":"5","author":"Burish","year":"2015","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0016","article-title":"Classical hallucinogens as antidepressant drugs: a cautionary approach","author":"Dos Santos","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"Pt B","key":"10.1016\/j.euroneuro.2024.05.002_bib0017","article-title":"Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience","volume":"121","author":"Dos Santos","year":"2021","journal-title":"Epilep. Behav.: E&B"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.05.002_bib0018","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.euroneuro.2023.12.006","article-title":"Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): a phase I clinical trial","volume":"80","author":"Falchi-Carvalho","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.05.002_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0021","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.05.002_bib0022","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.05.002_bib0023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JCP.0000000000001343","article-title":"Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series","volume":"41","author":"G\u00f3mez-Sousa","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.05.002_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"12","key":"10.1016\/j.euroneuro.2024.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.05.002_bib0026","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13181-016-0593-1","article-title":"Ayahuasca exposure: descriptive analysis of calls to US poison control centers from 2005 to 2015","volume":"13","author":"Heise","year":"2017","journal-title":"J. Med. Toxicol.: Off. J. Am. Coll. Med. Toxicol."},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0027","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1176\/ajp.125.10.1352","article-title":"A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics","volume":"125","author":"Hollister","year":"1969","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102206","article-title":"Ayahuasca and the traveller: a scoping review of risks and possible benefits","volume":"44","author":"Houle","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0029","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1172\/JCI38832","article-title":"Disruptive insights in psychiatry: transforming a clinical discipline","volume":"119","author":"Insel","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.05.002_bib0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.05.002_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression: first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0033","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1098-2779(2000)6:4<242::AID-MRDD3>3.0.CO;2-W","article-title":"Age-dependent consequences of seizures: relationship to seizure frequency, brain damage, and circuitry reorganization","volume":"6","author":"Lado","year":"2000","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"12","key":"10.1016\/j.euroneuro.2024.05.002_bib0034","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0269881118793086","article-title":"Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016","volume":"32","author":"Leonard","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0269881121991554","article-title":"Connected to the spirit of the frog: an Internet-based survey on Kamb\u00f4, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): motivations for use, settings and subjective experiences","volume":"35","author":"Maji\u0107","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"543","key":"10.1016\/j.euroneuro.2024.05.002_bib0036","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.118.543.229","article-title":"Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom","volume":"118","author":"Malleson","year":"1971","journal-title":"Brit. J. Psychiatry: J. Ment. Sci."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.05.002_bib0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0038","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11419-017-0394-5","article-title":"Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry","volume":"36","author":"de Morais","year":"2018","journal-title":"Forensic Toxicol"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.05.002_bib0039","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0041","article-title":"The illusion of knowledge in the emerging field of psychedelic research","volume":"67","author":"Ona","year":"2022","journal-title":"New Idea. Psychol."},{"issue":"11","key":"10.1016\/j.euroneuro.2024.05.002_bib0042","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/brainsci11111384","article-title":"Epilepsy and ecstatic experiences: the role of the insula","volume":"11","author":"Picard","year":"2021","journal-title":"Brain Sci."},{"issue":"49","key":"10.1016\/j.euroneuro.2024.05.002_bib0043","first-page":"6","article-title":"Potential Interaction of LSD and Fluoxetine SIR: we report a case of grand mal convulsions","volume":"1","author":"Picker","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0044","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fpsyt.2019.00896","article-title":"Population survey data informing the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics","volume":"10","author":"Sexton","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.05.002_bib0045","article-title":"Prevalence and associations of classic psychedelic-related seizures in a population-based sample","volume":"239","author":"Simonsson","year":"2022","journal-title":"Drug. Alcoh. Depend."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.05.002_bib0046","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2005.04.012","article-title":"Psychiatric comorbidity in epilepsy","volume":"7","author":"Swinkels","year":"2005","journal-title":"Epilep. Behav.: E&B"},{"issue":"10","key":"10.1016\/j.euroneuro.2024.05.002_bib0047","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1021\/acsptsci.3c00137","article-title":"The psychedelic N,N-dipropyltryptamine prevents seizures in a mouse model of fragile X syndrome via a mechanism that appears independent of serotonin and sigma1 receptors","volume":"6","author":"Tyagi","year":"2023","journal-title":"ACS Pharmacol. Translat. Sci."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.05.002_bib0048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2012.05.024","article-title":"Lamotrigine in epilepsy, pregnancy and psychiatry\u2013a drug for all seasons?","volume":"20","author":"Vajda","year":"2013","journal-title":"J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas."},{"issue":"17","key":"10.1016\/j.euroneuro.2024.05.002_bib0049","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2400110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2400110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:39:07Z","timestamp":1722029947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2400110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"alternative-id":["S0924977X2400110X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.05.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do classic psychedelics increase the risk of seizures? A scoping review","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}